The annual shareholders meeting has been stretched out for several years so that they can have it right near ASCO now if they choose to delay again. My guess is they will have something very important to present at ASCO beyond just the L trial data which should be old news by then. Best wishes.
ASM will be early this year, IMO, like end of February. If so, it will be an indication of positive results. Why? LP will need a lot of money to push approvals through. We are technically over our authorized share level. She needs a vote to approve either a reverse split or to increase authorized shares. I don't think either get approved without topline release and peer-reviewed article first.
News 
Market Data 
Discover 
